|Day Low/High||0.34 / 0.37|
|52 Wk Low/High||0.14 / 0.83|
Alzheimer's Licensing Agreement Highlights Cannabis-Based IP Portfolio Targeting Large Market Conditions
Core Operations Transitioned to Phytocannabinoid-Based Therapy Development Targeting Large Market Indications
Consolidates Corporate Focus to the Development of Cannabis-Based Combination Therapies
Transitions Management to Focus on Cannabis-based Therapies
HBA Architecture Appointed as Master Planner and Design Architect
Strengthens International Infrastructure & Real Estate Management Unit
Expands Phytocannabinoid IP Portfolio
Expansion Based on U.S. Provisional Patent Portfolio
Exchanges Minority Interest for 5 Acres of Prime Land in India
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.